Insiders who reported open-market trades in the last 12 months at the companies David James Lennon files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Scott M. Giacobello - $891K in WHWK purchases and sales in the last 12 months
Bryan Ball - $635K in WHWK purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
David James Lennon is a corporate insider, tracked as CHIEF EXECUTIVE OFFICER, Director of Whitehawk Therapeutics, Inc. (WHWK). InsiderAlpha holds 8 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has David James Lennon submitted recently?
2 primary Form 4 filings in the last 90 days, covering 1 company.
Has David James Lennon been buying or selling stock?
Recorded transactions: 0 open-market purchases and 7 open-market sales ($1.08M) across all tracked filings.
David James Lennon is CHIEF EXECUTIVE OFFICER, Director of Whitehawk Therapeutics, Inc. (WHWK). 8 SEC Form 4 filings on record going back to 2024, most recently on 18 September 2026. Most recent open-market trade: sold $49K of WHWK on 10 April 2026. Lifetime open-market sales: $1.08M.
Recent transactions
11
The latest 11 SEC Form 4 transactions reported by David James Lennon.
InsiderAlpha's records for David James Lennon go back to 2024: 8 primary Form 4 filings, an average of 2.7 per year. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.
